Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Entecavir (0.5mg) Tablet
Therapeutic Category
Antiviral, Gastroenterology, Hepatology
Dosage Form
Tablet
Packaging Type
in a Bottle
Packaging
30 Tablets
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Viraent 0.5 Tablet contains Entecavir 0.5mg, an antiviral medicine used in the treatment of chronic Hepatitis B infection. It works by inhibiting HBV DNA polymerase, thereby reducing viral load and preventing virus multiplication. This helps in improving liver function and slowing down disease progression.
It belongs to the antiviral and hepatology therapy segment and is widely prescribed by gastroenterologists and hepatology specialists for long-term management of chronic Hepatitis B.
For PCD pharma franchise partners, wholesalers, and exporters, Viraent 0.5 Tablet offers a high-value business opportunity due to consistent demand in chronic care therapy. It is available for bulk orders, monopoly-based PCD franchise rights, institutional supply, export, and private label third-party manufacturing.
Common side effects may include headache, fatigue, dizziness, nausea, and trouble sleeping. Rarely, lactic acidosis may occur with long-term use.
Viraent 0.5 Tablet is primarily indicated for chronic Hepatitis B infection in adults with active viral replication or elevated liver enzymes.
Use only under strict medical guidance. It should not be stopped abruptly as it may cause viral flare-up. Dose adjustments may be required in kidney impairment.
Store in a cool and dry place below 25°C, away from light and moisture. Keep out of the reach of children.
Composition : Salmeterol (25mcg) + Fluticasone Propionate (500mcg)
Composition : Salmeterol (25mcg) + Fluticasone Propionate (250mcg)
Composition : Formoterol (12mcg) + Tiotropium (18mcg)
Composition : Tiotropium (9mcg)
Composition : Formoterol (6mcg) + Fluticasone Propionate (250mcg)
Composition : Formoterol (6mcg) + Budesonide (400mcg) Inhaler
Composition : Formoterol (6mcg) + Budesonide (200mcg) Inhaler
Composition : Levosalbutamol (50mcg) + Ipratropium (20mcg)
Composition : Salmeterol (50mcg) + Fluticasone Propionate (250mcg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Entecavir 0.5mg Tablet is a widely used antiviral medicine for chronic Hepatitis B management, making it a strong specialty prescription product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand in Hepatitis B treatment, long-term antiviral therapy, liver disease management, and chronic infection control. It is commonly prescribed by hepatologists, gastroenterologists, and physicians for viral suppression and liver protection.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Entecavir 0.5mg Tablet with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from steady long-term prescription demand, chronic therapy usage, and strong acceptance in hepatology and gastroenterology segments when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this antiviral formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.